The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

NCT02403284 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

97

Enrollment

FED

Sponsor class

Conditions

Insulin Resistance

Interventions

DRUG: Liraglutide
DRUG: Sugar Pill

Sponsor

Phoenix VA Health Care System

Collaborators

[object Object]